The present disclosure relates to surgical systems, and more particularly, to systems and methods for modeling the lungs of a patient using computed tomography (CT) data.
As technology has advanced, surgeons have begun to replace classical open surgical techniques with minimally invasive techniques such as laparoscopic and thoracoscopic surgery in an effort to minimize trauma to surrounding tissue, reduce pain, reduce scarring, and reduce the length of time the patient is required to stay in the hospital. Minimally invasive surgery, such as the thoracoscopic approach pioneered in the mid-19th century, involves the use of small incisions (from one to several), typically no larger than 3-10 mm. Originally performed using a cystoscope, advances in medical technology lead to the development of specialized instruments for use in the thoracic cavity, such as a thoracoscope, to view the anatomy within the thoracic cavity while performing the surgical procedure. In the late 20th century, Video Assisted Thoracic Surgery (VATS) was developed utilizing a fiber-optic endoscope to further reduce the size of the incisions required to perform the procedure and to provide clearer, more defined images of the thoracic cavity.
Concurrently, advances in medical imaging have enabled clinicians to more accurately depict the anatomy of a patient, and therefore, more accurately identify diseases and the location of any diseased tissue. These advances have enabled clinicians to more efficiently utilize minimally invasive surgical techniques, such as the thoracoscopic approach described above. Using medical imaging, such as CT (including X-ray CT, computerized axial tomography (CAT) scan, positron emission tomography (PET), and single-photon emission CT (SPECT)), a clinician is able to accurately identify lesions or other medical conditions without the need for invasive surgeries (such as an open approach or thoracotomy). Further, three-dimensional reconstructions of organs, anatomical structure, or the like are developed using the images obtained using one of the above noted imaging modalities. Using the three-dimensional model, a clinician is able to segment various tissues from one another and assess an accurate location of the lesion within the thoracic cavity, or in one particular example, within the lungs. This segmentation further enables a clinician to determine the precise tissue segment with its affiliated vessel and bronchial branches and determine the ideal incision level for VATS procedures (such as a segmentectomy, lobectomy, pneumonectomy, or the like). The three-dimensional model and precise identification of the lesion within the lung and its associated vessel and bronchial branches enables clinicians to identify an ideal location for port placement and develop a pathway through which the surgical instruments should be guided during the thoracoscopic procedure. Typically, a fiducial or other marker (e.g., coils or wires) is implanted within the affected tissue using fluoroscopy or other imaging modalities. Thereafter, the location of the fiducial relative to the lesion is checked using imaging and the VATS procedure is performed. However, it is possible for the fiducial to migrate within the tissue, leading to inaccurate identification of the lesion during the VATS procedure, thereby leading to sub-optimal results.
In order to alleviate this issue, image-guided VATS (iVATS) was developed, which incorporates intraoperative imaging (such as fluoroscopy) to help guide the surgical tools to the identified lesion. In this manner, a clinician preoperatively plans the trajectory for the surgical tools (fiducials, forceps, staplers, or the like) and monitors their location within the thoracic cavity using intraoperative imaging.
However, as is typical during a thoracoscopic procedure, it is necessary to deflate a portion of the patient's lungs (i.e., induce atelectasis) in order to provide the requisite space within the thoracic cavity for the surgical tools to be maneuvered. Because VATS and iVATS procedures reconstruct the lung using preoperative imaging modalities, the three-dimensional reconstruction is necessarily of an inflated lung. Therefore, because the patient's lungs are deflated during the procedure, the actual geometry of the patient's lungs has changed relative to the three-dimensional reconstruction, leading to a shift in the location of the lesion within the lungs and thoracic cavity. As a result, the preoperative plan is no longer accurate and the clinician is required to compensate for the altered geometry of the lung during the surgical procedure, extending the length of the procedure and increasing the probability of errors.
The present disclosure is directed to a system for modeling a collapsed lung of a patient. The method includes acquiring computer tomography (CT) data of a patient's lungs, storing a software application within a memory associated with a computer, the computer having a processor configured to execute the software application, executing the software application to differentiate tissue located within the patient's lung using the acquired CT data, generate a 3-D model of the patient's lungs based on the acquired CT data and the differentiated tissue, apply a material property to each tissue of the differentiated tissue within the generated 3-D model, generate a mesh of the generated 3-D model based on the material property applied to the differentiated tissue and the generated mesh of the generated 3-D model, calculate a displacement of the patient's lungs in a collapsed state, and display a collapsed lung model of the patient's lungs based on the calculated displacement of the patient's lungs.
In a further aspect, differentiating tissue located within the patient's lungs may include grouping similar types of tissue based on a corresponding contrast density associated with the tissue.
In another aspect, differentiating tissue located within the patient's lungs may include identifying low contrast density tissue and high contrast density tissue.
In yet another aspect, identifying low contrast density tissue may include identifying at least one structure from the group consisting of lung parenchyma, pleura fissure lines, and bronchi.
In still another aspect, identifying high contrast density tissue may include identifying at least one structure from the group consisting of luminal structures, hilar structures, and bronchopulmonary lymph nodes.
In another aspect, the method may further include selecting a contrast density tissue from the identified low contrast density tissue and high contrast density tissue and generating an offset shell to represent adjacent structure.
In yet another aspect, the method may further include generating a constraint using an offset shell to create a boundary condition that constrains the calculated displacement of the lung.
In a further aspect, the method may further include applying a directional effect of gravity to the generated 3-D model.
In still another aspect, the method may further include calculating a curvature of the patient's spine in a coronal plane.
In yet another aspect, the method may further include calculating a reduction in lung volume based on the calculated curvature of the patient's spine.
In a further aspect, the method may further include altering the generated 3-D model to reflect the calculated reduction in lung volume.
In another aspect, the method may further include identifying adhesions within a thoracic cavity of the patient and displaying the 3-D model of the patient's lungs as sitting higher in the thoracic cavity of the patient.
In still another aspect, generating a mesh of the generated 3-D model of the patient's lungs may include applying a smoothing algorithm to the 3-D model.
In yet another aspect, the method may further include advancing a surgical instrument within a thoracic cavity of the patient to acquire positional data corresponding to an actual collapsed lung of the patient.
In a further aspect, advancing the surgical instrument within the thoracic cavity may include advancing a surgical instrument having a structured light scanner disposed on a distal portion thereof within the thoracic cavity of the patient, the structured light scanner configured to obtain the positional data of the actual collapsed lung of the patient.
In another aspect, calculating the displacement of the patient's lungs in a collapsed state may include calculating a plurality of displacements of the patient's lungs in a collapsed state, each calculated displacement of the plurality of calculated displacements of the patient's lungs based on a corresponding plurality of lung deflation levels.
In still another aspect, the method may further include selecting a calculated displacement of the plurality of displacements correlating to the positional data obtained by the structured light scanner and displaying a collapsed lung model of the patient's lungs based upon the selected calculated displacement of the patient's lungs.
In yet another aspect, the method may further include recalculating the displacement of the patient's lungs in a collapsed state based on the calculated offset between the first and second fiducials and displaying a regenerated collapsed lung model of the patient's lungs based on the recalculated displacement of the patient's lungs.
In another aspect, advancing the surgical instrument within the thoracic cavity of the patient may include advancing a surgical instrument having a camera disposed on a distal portion thereof configured to display real-time video images of the patient's collapsed lung within the thoracic cavity of the patient, wherein the collapsed lung model is superimposed over the displayed real-time video images of the patient's collapsed lung.
Various aspects and features of the present disclosure are described hereinbelow with reference to the drawings, wherein:
The present disclosure is directed to methods and systems for modeling the lungs of a patient using computed tomography (CT) data. As described herein, the clinician is able to review CT data of the patient to identify an area of interest illustrating the effects of lung disease. A pathway to the identified area of interest is generated and illustrated on a suitable display of a user interface such that the clinician may use the generated pathway to guide a surgical tool or other device (e.g., an ablation probe, a biopsy device, or the like) to the area of interest and treat the affected tissue. Using the CT data, a 3-D model of the patient's lungs is generated and presented to the clinician via the display. This 3-D model is segmented to define the boundaries of various types of tissue and group together similar types of tissue, such as low contrast density details of the lung (e.g., lung parenchyma, pleura fissure lines, bronchi, and the like) and high contrast density details of the lung (e.g., liminal structures, hilar structures, bronchopulmonary lymph nodes, or the like). The clinician is further able to manually identify the various structures of the lung to complete segmentation of the 3-D model and may confirm that the arteries, veins, and bronchi have been properly differentiated. A smoothing filter is applied to the segmentation of the lung and the 3-D model is reconstructed and displayed in a user interface via the display. In order to most accurately depict the patient's collapsed lung, the 3-D reconstruction is rotated via the user interface to ensure that the patient's lungs appear in the lateral decubitus position (i.e., as if the patient is lying on his or her side), which is the position in which the patient will typically be positioned during the surgical procedure. The curvature of the spine in the coronal or frontal plane is also calculated and utilized to accurately depict the patient's lung volume within the thoracic cavity.
The accuracy of the collapsed model of the lung is also affected by differing material properties, such as elastic modulus, of the low contrast density details and the high contrast density details of the lung. Specifically, the low contrast density details will shrink and/or contract under compression, whereas the high contrast density details tend to maintain their geometry and instead curl or bend. Therefore, the elastic modulus associated with the differentiated structures of the lungs is assigned to ensure that the collapsed model of the lung accurately depicts a real time view of the patient's collapsed lungs. As can be appreciated, in certain instances a nonlinear tissue material response such as hyperelastic model may be assigned to improve the accuracy in representing nonlinear material behavior. Similarly, various other structures located within the thoracic cavity may be identified, such as adhesions, lesions, or the like, and the 3-D model will accommodate these structured by readjusting the model within the thoracic cavity according to the placement of these structures. Gravity also effects how the collapsed lung rests within the thoracic cavity, and therefore, the directional effect of gravity is applied to the 3-D model depending upon the orientation in which the patient is lying on the operating table. Additionally, the degree of tilt of the operating table is also taken into account when applying the directional effect of gravity.
A secondary smoothing algorithm is applied to the 3-D model and thereafter, the 3-D model is meshed in preparation for Finite Element Analysis. Additionally, boundary conditions and loads are applied on the various parts of the model to represent the various attachments and constraints on the lungs, airways, blood vessels. The FEA process is utilized to calculate the displacement of the collapsed lung and ultimately present the collapsed lung model to the clinician via the display. The pathway to the area of interest described above is generated and superimposed on the collapsed lung model such that the clinician may navigate the surgical tool to the area of interest using VATS, iVATS, or any suitable electromagnetic navigation system.
The collapsed model of the lung is superimposed over a real-time view of the patient's lungs such that the clinician may view the various structures within the lung as a thoracoscope and other surgical instruments are navigated within the thoracic cavity and/or lungs. Using the thoracoscope, the clinician compares the collapsed lung model to the real-time view of the patient lungs and can manipulate the collapsed lung model to more accurately reflect the actual volume of the patient's collapsed lung. In this manner, a thoracoscope having a structured light scanner or other suitable device is used to obtain volumetric data of the patient's collapsed lung. This data is utilized to closely match the collapsed lung model to the real-time view of the collapsed lung. The systems and methods of the present disclosure enable a clinician to more accurately treat affected tissue within the patient's lung to reduce the time to complete the surgical procedure and avoid costly clinician errors.
Although the systems and methods detailed herein are generally described with respect to the lungs, it is contemplated that the following systems and methods may be applied to the liver, spleen, or any other organ.
Embodiments of the present disclosure are now described in detail with reference to the drawings in which like reference numerals designate identical or corresponding elements in each of the several views. As used herein, the term “clinician” refers to a doctor, a nurse, or any other care provider and may include support personnel. Throughout this description, the term “proximal” will refer to the portion of the device or component thereof that is closer to the clinician and the term “distal” will refer to the portion of the device or component thereof that is farther from the clinician. Additionally, in the drawings and in the description that follows, terms such as front, rear, upper, lower, top, bottom, and similar directional terms are used simply for convenience of description and are not intended to limit the disclosure. Although generally described herein as the various determination and/or selection steps being performed by a clinician, it is contemplated that the determination and/or selection steps described herein may be performed by the software application, or a combination of clinician and software application input. As can be appreciated, in certain instances, it may be necessary for the software application to make certain determinations, whereas in other instances it may be necessary for the clinician to make certain determinations. In embodiments, the software application may make a determination and present the determination to the clinician for selection and/or confirmation. In other embodiments, it may be necessary for the software application to provide a prompt or other warning to the clinician regarding the consequences of the clinician's decision, or to provide an alternative selection to the clinician, or combinations thereof. In the following description, well-known functions or constructions are not described in detail to avoid obscuring the present disclosure in unnecessary detail.
As illustrated in
With reference to the flow chart depicted in
Following imaging of the patient, in step S102, a software application stored within the memory is executed by a processor associated with the computer to enable review of the image data. One example of such an application is the ILOGIC® planning and navigation suites currently marketed by Medtronic. An area of interest (“AOL”
Referring to
Referring to
In step S106, the software application applies an image smoothing filter to the segmentation of the lung “L” prior to reconstructing the generated 3-D model of the lung “L”. As can be appreciated, the image smoothing filter may be any suitable image smoothing filter known in the art. The software application then reconstructs the 3-D model or representation of the lung “L” using any suitable 3-D rendering process or technique known in the art and displays the 3-D model via the user interface 20 (
As can be appreciated, the patient “P” is typically imaged while lying in the supine decubitus position such that the patient “P” is lying on his or her back. Accordingly, in step S108, the clinician rotates the generated 3-D model to appear in the lateral decubitus position as if the patient “P” is laying on his or her side. This can be accomplished using any suitable user input device such as a mouse, keyboard, or the like (not shown) to click and drag the 3-D model within the user interface 20 (
Utilizing the CT data obtained in step S100, the clinician calculates the curvature of the spine in the coronal or frontal plane which is the plane dividing the patient's “P” body into ventral and dorsal sections in step S110 and enters the calculated curvature of the spine into the user interface 20. As can be appreciated, the curvature of the spine in the coronal plane affects lung volume, particularly one side of the thoracic cavity over the other, depending on the direction of the curvature of the spine. It is envisioned that a table or other suitable database containing information correlating spinal curvature to lung volume may be stored in the memory coupled to the computer 10. In this manner, the software application may calculate the reduction in lung volume as a result of the inputted spinal curvature and alter the 3-D model presented to the clinician accordingly. Additionally, the altered lung volume is utilized when generating the compressed lung model, as will be described in further detail hereinbelow.
As can be appreciated, when subjected to compression, the various structures of the lungs “L” deform or compress at differing rates and by differing volumes. In particular, the low contrast density details “LC” (e.g., lung parenchyma, pleura fissure lines and bronchi, and the like) will shrink and/or contract under compression, resulting in a changing of distances between structures in the lung “L”. In contrast, the high contrast density details “HC” (e.g., luminal structures, hilar structures, bronchopulmonmary lymph nodes, and the like) will curve or bend but maintain their geometry, thereby remaining within the smaller total volume of the lung “L” resulting from the applied compression. This variance amongst the different structures within the lung “L” is a result of density-dependent material properties, such as a density-dependent elastic modulus (e.g., Young's modulus) associated with each structure. To account for differences in elasticity, the clinician assigns each identified volume an elastic modulus in step S112, which is utilized by the software application when calculating the deformed model of the lung “L.” As can be appreciated, additional properties, such as Poisson's ratio or the like, may be assigned to the differentiated structures, and in particular, to the lung parenchyma, which has a variable compressibility stemming from removal of air during the deflation of the lung “L.” In an instance where the loss of the air mass within the lung parenchyma is considered to be insignificant, the clinician may opt to assign the lung parenchyma its density dependent elasticity and compressibility via the user interface 20. Alternatively, where the loss of the air mass is considered to affect the elasticity of the lung parenchyma, the software may adjust the density dependent elasticity and compressibility of the lung parenchyma via the user interface 20 in order to best match the actual lung displacement, attained either by optical surface imaging/mapping or by best fit as identified by the clinician.
It is envisioned that additional structures within the thoracic cavity can be identified in the 3-D model, such as adhesions “A,” lesions, or the like. Specifically, any adhesions “A” that may be present may be recognized by the software application via the CT data. Alternatively, it is contemplated that the clinician may manually add or identify adhesions “A” via the user interface 20. In embodiments, the software application may account for adhesion “A” presence by forcing the lung “L” to sit higher in the thoracic cavity, by fixing the adhesions “A” to the fixed boundary at the ribcage and applying elastic models to determine displacement, or combinations thereof. Conversely, the software application may recognize the removal of adhesions “A,” or the removal of the adhesions “A” may be manually entered into the software application by the clinician, and the software application will readjust the model accordingly (e.g., the lung “L” will sit further down towards the hilum). The software application can also assign higher or lower elastic properties to non-structural portions of the pre-deflation lung volume based on the CT data or by manual input by the clinician. In this manner, tumor (or other lesion) volumes can be assigned a more rigid behavior (e.g., less prone to being compressed) and the displacement of the model will be recalculated accordingly, as will be described in further detail hereinbelow. Additionally, it is contemplated that the software application may use information from patient electronic medical records (EMR) to estimate a more likely level of lung deflation as the elastic properties of the lung tissues will be affected by common lung conditions such as chronic obstruction pulmonary disorder (COPD). As can be appreciated, the patient EMR may be accessed by the software application using any suitable means, such as via the memory coupled to the computer 10 (
In step S114, the clinician applies the directional effect of gravity on the 3-D model. It is envisioned that any suitable algorithm or means for applying the directional effect of gravity known in the art may be utilized. As can be appreciated, the orientation of the 3-D model within the user interface 20 (
Once the 3-D model is generated and segmentation has been completed, in step S116, the software application applies a secondary smoothing algorithm to prepare the 3-D model for meshing. As can be appreciated, a 3-D model having rough edges which may give rise to malformed elements (e.g., edge inversion, concave elements, or the like), results in an inaccurate solution or needlessly complex mesh solutions. The secondary smoothing algorithm ensures that the generated mesh that is valid. It is contemplated that the secondary smoothing algorithm may be any suitable smoothing algorithm known in the art capable of smoothing a 3-D model in preparation for meshing the model for Finite Element Analysis (FEA).
After completion of the secondary smoothing algorithm, the 3-D model is meshed (See
Additionally, the clinician may select the type of element “E” to be used in the mesh, such as tetrahedral, hexahedral, mixed-element, combinations thereof, or any other suitable element “E” type known in the art. It is further contemplated that the clinician may assign different mesh types to different segments of the lung “L,” depending on the type of tissue and the geometry of the segment. Alternatively, it is contemplated that the software application may automatically assign the element “E” type to be used during the generation of the mesh depending on the computing power available and the needs of the procedure being performed. It is envisioned that the 3-D mesh may be generated using any suitable technique known in the art, such as the marching cubes technique, the advancing front technique, the red green tetrahedral technique, marching cubes with Delaunay-based meshes, variational tetrahedral meshing, hexahedral meshes, mesh adaptation techniques such as the mesh-matching algorithm, meshing 4-D domains, mesh warping, and the like. It is envisioned that any suitable segmentation and meshing program may be utilized to generate the meshing, such as those marketed and sold by Materialize NV, such as Mimics or 3matic. In embodiments, segmentation and meshing may be completed using the Emprint™ ablation system or superDimension™ navigation system marketed and sold by Medtronic.
It is envisioned that simplification of the representation of structures and organs surrounding the patient's lungs may be performed for modeling the displacement and motion of the lungs in the collapsed state. It is contemplated that additional geometries may be created by translating and offsetting (dilation or contraction) existing geometries to provide boundary constraints on the lungs. For instance, the surface of the lung parenchyma may be expanded to create an offset shell surface that can be used to provide an envelope within which the lung has to reside during the collapse. In embodiments, other structures or organs (e.g., parenchyma, pleura, hilar, mediastinum, heart, etc.) may be represented by selecting a low contrast density or high contrast density tissue and creating an offset shell or envelope. Additionally, it is contemplated that boundary conditions that fully or partially constrain the density of the lung or adjacent tissue (e.g., pleura, the diaphragm, hilar structures, the heart, the chest wall, etc.) can be assigned by creating offset shells or envelopes. It is further contemplated that contact between the parenchyma and the organs and structures surrounding the lungs can be reduced to only contact between the lung and the offset shell envelope. It is envisioned that further refinement may be added to the offset shell representation by treating the offset shell representation as a rigid structure or specifying stiffnesses (or elasticities) in different regions corresponding to the modulus of the neighboring tissue. Additionally, differential pressure loads may be applied on various surfaces (lung parenchyma, airways, etc.) and the collapse of the lung is solved by Finite Element Analysis.
The resulting meshed 3-D model forms a Computational Lung Model (CLM), which is the 3-D model that is displayed to the clinician on the display associated with the computer 10 or the monitoring equipment 30 (
In step S118, the displacement of the collapsed lung “L” is calculated (See
It is contemplated that the clinician may select a desired level of lung deflation depending upon his/her experience and/or interpretation of the patient's condition. The clinician may either increase or decrease the amount of lung deflation such that the predicted model may more closely resemble observed conditions. As can be appreciated, a series of solutions using a variety of loading and material arrangements may be calculated by the system depending on the computation load, mesh size requirements, and available computational power. By calculating several solutions, the clinician is able to select the solution that most closely matches the patient “P” at the time the procedure. At this point, the preoperative constructs of the CLM are complete and in step S120, the clinician proceeds to preoperative planning utilizing the CLM generated as a result of the procedure described hereinabove.
During preoperative planning, the clinician utilizes the software application to determine a pathway through which the surgical tools used to treat the area of interest “AOI” may be advanced within the patient “P.” Additionally, the software application may identify an optimal location at which a trocar or port may be introduced to most easily reach the area of interest “AOI” using a surgical tool 80, as shown in
Referring now to the flow chart depicted in
As can be appreciated, if the clinician manipulated the orientation of the CLM within the user interface 20 (
In step S128 the clinician may advance a thoracoscope 60 (
If several solutions for the CLM are calculated in step S118 (detailed hereinabove), using the positional data obtained by the structured light scanner 62 (
The offsets calculated in step S134 are applied as explicit displacements through the FEA program to the CLM. The remaining mesh points are then recalculated to include these new positions and in step S136, the CLM is regenerated using the new positions to more accurately reflect the observed condition of the patient's collapsed lung “L.” It is contemplated that the regenerated CLM may be selectively overlaid with the clinician's actual view of the patient's “P” lung surface displayed on the display associated with the computer 10 or the monitoring equipment 30 (
In another embodiment, it is contemplated that the elastic properties that are assigned to the various structures of the lung “L” may be modified and the CLM recalculated in order to obtain a better match between the CLM and the scan obtained by the structured light scanner 62 (
It is further contemplated that rather than comparing the CLM to the scan obtained by the structured light scanner 62, the CLM may be compared to the clinician's real-time view of the collapsed lung obtained by the thoracoscope 60 (
As the thoracoscope 60 (
As noted hereinabove, VATS or iVATS may be utilized to navigate the surgical tool 80 (
The navigation system may be a six degree-of-freedom electromagnetic tracking system 110, e.g., similar to those disclosed in U.S. patent application Ser. No. 14/753,288 to Brown et al. entitled “System and Method for Navigating within the Lung,” filed Jun. 29, 2015 and published PCT Application Nos. WO 00/10456 and WO 01/67035, the entire content of each of which is incorporated herein by reference, or another suitable positioning measuring system, is utilized for performing registration and navigation, although other configurations are also contemplated. Tracking system 110 includes tracking module 112, a plurality of reference sensors 114, and a transmitter mat 116. The tracking system 110 is configured for use with the surgical tool 80 having the sensor 80a disposed at a distal portion thereof that enables monitoring of the position and orientation of the distal portion of the surgical tool 80, in six degrees of freedom, relative to the reference coordinate system. For a detailed description of the construct of exemplary navigation systems, reference can be made to U.S. Patent Application Publication No. 2015/0265257 to Costello et al. entitled “Systems, and Methods for Navigating a Biopsy Tool to a Target Location and Obtaining a Tissue Sample Using the Same,” filed Dec. 9, 2014, the entire content of which is incorporated by reference herein.
The transmitter mat 116 is positioned beneath the patient “P” and is a transmitter of electromagnetic radiation and includes a stack of three substantially planar rectangular loop antennas (not shown) configured to be connected to drive circuitry (not shown). For a detailed description of the construction of exemplary transmitter mats, which may also be referred to as location boards, reference may be made to U.S. Patent Application Publication No. 2009/0284255 to Zur entitled “Magnetic Interference Detection System and Method,” filed Apr. 2, 2009, the entire contents of which is incorporated by reference herein.
The transmitter mat 116 and the plurality of reference sensors 114 are interconnected with tracking module 112, which derives the location of each sensor 114 in six degrees of freedom. One or more of the reference sensors 114 are attached to the chest of the patient “P.” The six degrees of freedom coordinates of the reference sensors 114 are sent to the computer 10 (which includes the appropriate software) where they are used to calculate a patient coordinate frame of reference. Registration is generally performed by identifying locations in both the 3-D model and the patient's “P” thoracic cavity and/or lungs “L” and measuring the coordinates in both systems. These coordinates are then correlated and the two coordinate systems are aligned.
In use, the surgical tool 80 is advanced within the thoracic cavity of the patient “P.” Automatic registration is performed by moving the surgical tool 80 through the thoracic cavity. More specifically, data pertaining to locations of the sensor 80a while the surgical tool 80 is moving through the thoracic cavity is recorded using the tracking module 112, the reference sensors 114, and the transmitter mat 116. A shape resulting from this location data is compared to an interior geometry of the thoracic cavity and/or lungs “L” of the 3-D model generated using the methods described hereinabove, and a location correlation between the shape and the 3-D model based on the comparison is determined, e.g., utilizing the software on computer 10. It is contemplated that the location of the distal portion of the surgical tool may be displayed on the 3-D model or CLM such that the clinician may identify the position of the surgical tool 80 within the thoracic cavity and/or lungs “L” of the patient “P.”
Referring again to
Once the surgical tool 80 has been successfully navigated to the area of interest “AOI,” the clinician may remove or otherwise treat the area of interest “AOI” using the surgical tool 80. For a detailed description of exemplary planning and navigation of a surgical tool, reference may be made to U.S. patent application Ser. No. 14/753,288 to Brown et al., previously incorporated by reference herein.
The electromagnetic waves generated by the transmitter mat 116 are received by the various sensor elements configured for use with the surgical tool 80, and are converted into electrical signals that a sensed via the reference sensors 114. The tracking system 110 further includes reception circuitry (not shown) that has appropriate amplifiers and A/D converters that are utilized to receive the electrical signals from the reference sensors 114 and process these signals to determine and record location data of the sensor assembly. The computer 10 may be configured to receive the location data from the tracking system 110 and display the current location of the sensor assembly on the CLM and relative to the selected pathway generated during the planning phase, e.g., on the computer 10, the monitoring equipment 30, or other suitable display. Thus, navigation of the surgical tool 80 to the area of interest “AOI” and/or manipulation of the surgical tool 80 relative to the area of interest “AOI,” as detailed above, can be readily achieved.
While several embodiments of the disclosure have been shown in the drawings, it is not intended that the disclosure be limited thereto, as it is intended that the disclosure be as broad in scope as the art will allow and that the specification be read likewise. Therefore, the above description should not be construed as limiting, but merely as exemplifications of particular embodiments.
This application is a Division of U.S. patent application Ser. No. 16/045,996, filed Jul. 26, 2018, entitled MODELING A COLLAPSED LUNG USING CT DATA, now U.S. Pat. No. 11,071,591.
Number | Name | Date | Kind |
---|---|---|---|
4202352 | Osborn | May 1980 | A |
5358496 | Ortiz et al. | Oct 1994 | A |
6086586 | Hooven | Jul 2000 | A |
6188355 | Gilboa | Feb 2001 | B1 |
6503195 | Keller et al. | Jan 2003 | B1 |
6533784 | Truckai et al. | Mar 2003 | B2 |
6656177 | Truckai et al. | Dec 2003 | B2 |
6802843 | Truckai et al. | Oct 2004 | B2 |
6833814 | Gilboa et al. | Dec 2004 | B2 |
6835336 | Watt | Dec 2004 | B2 |
6913579 | Truckai et al. | Jul 2005 | B2 |
7947000 | Vargas et al. | May 2011 | B2 |
8335359 | Fidrich et al. | Dec 2012 | B2 |
8706184 | Mohr et al. | Apr 2014 | B2 |
8827934 | Chopra et al. | Sep 2014 | B2 |
8828023 | Neff et al. | Sep 2014 | B2 |
9247992 | Ladtkow et al. | Feb 2016 | B2 |
9259269 | Ladtkow et al. | Feb 2016 | B2 |
9459770 | Baker | Oct 2016 | B2 |
9575140 | Zur | Feb 2017 | B2 |
9770216 | Brown et al. | Sep 2017 | B2 |
9801630 | Harris et al. | Oct 2017 | B2 |
9918659 | Chopra et al. | Mar 2018 | B2 |
10172973 | Vendely et al. | Jan 2019 | B2 |
10206686 | Swayze et al. | Feb 2019 | B2 |
10349938 | Widenhouse et al. | Jul 2019 | B2 |
10373719 | Soper et al. | Aug 2019 | B2 |
10376178 | Chopra | Aug 2019 | B2 |
10405753 | Sorger | Sep 2019 | B2 |
10478162 | Barbagli | Nov 2019 | B2 |
10480926 | Froggatt et al. | Nov 2019 | B2 |
10524866 | Srinivasan et al. | Jan 2020 | B2 |
10555788 | Panescu et al. | Feb 2020 | B2 |
10610306 | Chopra | Apr 2020 | B2 |
10638953 | Duindam et al. | May 2020 | B2 |
10674970 | Averbuch et al. | Jun 2020 | B2 |
10682070 | Duindam | Jun 2020 | B2 |
10706543 | Donhowe et al. | Jul 2020 | B2 |
10709506 | Coste-Maniere et al. | Jul 2020 | B2 |
10716637 | Kowshik et al. | Jul 2020 | B2 |
10729886 | Fenech et al. | Aug 2020 | B2 |
10743751 | Landey et al. | Aug 2020 | B2 |
10772485 | Schlesinger et al. | Sep 2020 | B2 |
10779803 | Prisco et al. | Sep 2020 | B2 |
10792022 | Keast et al. | Oct 2020 | B2 |
10792464 | Romo et al. | Oct 2020 | B2 |
10796432 | Mintz et al. | Oct 2020 | B2 |
10823627 | Sanborn et al. | Nov 2020 | B2 |
10827913 | Ummalaneni et al. | Nov 2020 | B2 |
10835153 | Rafii-Tari et al. | Nov 2020 | B2 |
10856855 | Gordon | Dec 2020 | B2 |
10881385 | Fenech | Jan 2021 | B2 |
10885630 | Li et al. | Jan 2021 | B2 |
20030013972 | Makin | Jan 2003 | A1 |
20030095692 | Mundy et al. | May 2003 | A1 |
20030164952 | Deichmann et al. | Sep 2003 | A1 |
20050165276 | Belson et al. | Jul 2005 | A1 |
20060235457 | Belson | Oct 2006 | A1 |
20070135803 | Belson | Jun 2007 | A1 |
20090284255 | Zur | Nov 2009 | A1 |
20110085720 | Averbuch | Apr 2011 | A1 |
20120190923 | Kunz et al. | Jul 2012 | A1 |
20130063434 | Miga et al. | Mar 2013 | A1 |
20130096385 | Fenech et al. | Apr 2013 | A1 |
20130096603 | Mathis et al. | Apr 2013 | A1 |
20130303945 | Blumenkranz et al. | Nov 2013 | A1 |
20140035798 | Kawada et al. | Feb 2014 | A1 |
20140052018 | Hawkins | Feb 2014 | A1 |
20140226884 | Porikli et al. | Aug 2014 | A1 |
20140235943 | Paris et al. | Aug 2014 | A1 |
20140336461 | Reiter et al. | Nov 2014 | A1 |
20150148690 | Chopra et al. | May 2015 | A1 |
20150254841 | Fujiwara et al. | Sep 2015 | A1 |
20150265257 | Costello et al. | Sep 2015 | A1 |
20150265368 | Chopra et al. | Sep 2015 | A1 |
20150305706 | Kanik et al. | Oct 2015 | A1 |
20160000302 | Brown et al. | Jan 2016 | A1 |
20160000356 | Brown et al. | Jan 2016 | A1 |
20160001038 | Romo et al. | Jan 2016 | A1 |
20160005193 | Markov et al. | Jan 2016 | A1 |
20160038248 | Bharadwaj et al. | Feb 2016 | A1 |
20160067450 | Kowshik | Mar 2016 | A1 |
20160073854 | Zeien | Mar 2016 | A1 |
20160157939 | Larkin et al. | Jun 2016 | A1 |
20160183841 | Duindam et al. | Jun 2016 | A1 |
20160192860 | Allenby et al. | Jul 2016 | A1 |
20160287344 | Donhowe et al. | Oct 2016 | A1 |
20160331358 | Gordon | Nov 2016 | A1 |
20160374676 | Flanagan et al. | Dec 2016 | A1 |
20170020628 | Averbuch | Jan 2017 | A1 |
20170112576 | Coste-Maniere et al. | Apr 2017 | A1 |
20170112588 | Bissing et al. | Apr 2017 | A1 |
20170135760 | Girotto et al. | May 2017 | A1 |
20170209071 | Zhao et al. | Jul 2017 | A1 |
20170224338 | Sung | Aug 2017 | A1 |
20170238795 | Blumenkranz et al. | Aug 2017 | A1 |
20170258309 | Deyanov | Sep 2017 | A1 |
20170265952 | Donhowe et al. | Sep 2017 | A1 |
20170274189 | Smith et al. | Sep 2017 | A1 |
20170280970 | Sartor et al. | Oct 2017 | A1 |
20170311844 | Zhao et al. | Nov 2017 | A1 |
20170319165 | Averbuch | Nov 2017 | A1 |
20180001058 | Schlesinger | Jan 2018 | A1 |
20180064904 | Vargas et al. | Mar 2018 | A1 |
20180078318 | Barbagli et al. | Mar 2018 | A1 |
20180153621 | Duindam et al. | Jun 2018 | A1 |
20180161102 | Wei et al. | Jun 2018 | A1 |
20180214138 | Prisco et al. | Aug 2018 | A9 |
20180221039 | Shah | Aug 2018 | A1 |
20180235709 | Donhowe et al. | Aug 2018 | A1 |
20180240237 | Donhowe et al. | Aug 2018 | A1 |
20180256262 | Duindam et al. | Sep 2018 | A1 |
20180263706 | Averbuch | Sep 2018 | A1 |
20180279852 | Rafii-Tari et al. | Oct 2018 | A1 |
20180325419 | Zhao et al. | Nov 2018 | A1 |
20190000559 | Berman et al. | Jan 2019 | A1 |
20190000560 | Berman et al. | Jan 2019 | A1 |
20190008413 | Duindam et al. | Jan 2019 | A1 |
20190038365 | Soper et al. | Feb 2019 | A1 |
20190065209 | Mishra et al. | Feb 2019 | A1 |
20190076143 | Smith | Mar 2019 | A1 |
20190110839 | Rafii-Tari et al. | Apr 2019 | A1 |
20190175062 | Rafii-Tari et al. | Jun 2019 | A1 |
20190183318 | Froggatt et al. | Jun 2019 | A1 |
20190183585 | Rafii-Tari et al. | Jun 2019 | A1 |
20190183587 | Rafii-Tari et al. | Jun 2019 | A1 |
20190192143 | Shelton, IV et al. | Jun 2019 | A1 |
20190192234 | Gadda et al. | Jun 2019 | A1 |
20190200984 | Shelton, IV et al. | Jul 2019 | A1 |
20190209016 | Herzlinger et al. | Jul 2019 | A1 |
20190209043 | Zhao et al. | Jul 2019 | A1 |
20190216548 | Ummalaneni | Jul 2019 | A1 |
20190223693 | Vargas | Jul 2019 | A1 |
20190231449 | Diolaiti et al. | Aug 2019 | A1 |
20190239723 | Duindam et al. | Aug 2019 | A1 |
20190239724 | Averbuch et al. | Aug 2019 | A1 |
20190239831 | Chopra | Aug 2019 | A1 |
20190246876 | Schaning | Aug 2019 | A1 |
20190250050 | Sanborn et al. | Aug 2019 | A1 |
20190254649 | Walters et al. | Aug 2019 | A1 |
20190269470 | Barbagli et al. | Sep 2019 | A1 |
20190269885 | Bailey et al. | Sep 2019 | A1 |
20190272634 | Li et al. | Sep 2019 | A1 |
20190290375 | Dearden et al. | Sep 2019 | A1 |
20190298160 | Ummalaneni et al. | Oct 2019 | A1 |
20190298451 | Wong et al. | Oct 2019 | A1 |
20190320878 | Duindam et al. | Oct 2019 | A1 |
20190320937 | Duindam et al. | Oct 2019 | A1 |
20190328213 | Landey et al. | Oct 2019 | A1 |
20190336238 | Yu et al. | Nov 2019 | A1 |
20190343424 | Blumenkranz et al. | Nov 2019 | A1 |
20190350659 | Wang et al. | Nov 2019 | A1 |
20190365199 | Zhao et al. | Dec 2019 | A1 |
20190365479 | Rafii-Tari | Dec 2019 | A1 |
20190365486 | Srinivasan et al. | Dec 2019 | A1 |
20190380787 | Ye et al. | Dec 2019 | A1 |
20200000319 | Saadat et al. | Jan 2020 | A1 |
20200000526 | Zhao | Jan 2020 | A1 |
20200008655 | Schlesinger et al. | Jan 2020 | A1 |
20200008827 | Dearden et al. | Jan 2020 | A1 |
20200022767 | Hill et al. | Jan 2020 | A1 |
20200029948 | Wong et al. | Jan 2020 | A1 |
20200030044 | Wang et al. | Jan 2020 | A1 |
20200030461 | Sorger | Jan 2020 | A1 |
20200030575 | Bogusky et al. | Jan 2020 | A1 |
20200038750 | Kojima | Feb 2020 | A1 |
20200043207 | Lo et al. | Feb 2020 | A1 |
20200046431 | Soper et al. | Feb 2020 | A1 |
20200046436 | Tzeisler et al. | Feb 2020 | A1 |
20200054399 | Duindam et al. | Feb 2020 | A1 |
20200060771 | Lo et al. | Feb 2020 | A1 |
20200069192 | Sanborn et al. | Mar 2020 | A1 |
20200069384 | Fenech et al. | Mar 2020 | A1 |
20200077870 | Dicarlo et al. | Mar 2020 | A1 |
20200077991 | Gordon et al. | Mar 2020 | A1 |
20200078095 | Chopra et al. | Mar 2020 | A1 |
20200078103 | Duindam et al. | Mar 2020 | A1 |
20200085514 | Blumenkranz | Mar 2020 | A1 |
20200100776 | Blumenkranz et al. | Apr 2020 | A1 |
20200107894 | Wallace et al. | Apr 2020 | A1 |
20200109124 | Pomper et al. | Apr 2020 | A1 |
20200121170 | Gordon et al. | Apr 2020 | A1 |
20200129045 | Prisco | Apr 2020 | A1 |
20200129239 | Bianchi et al. | Apr 2020 | A1 |
20200138515 | Wong | May 2020 | A1 |
20200146757 | Fenech et al. | May 2020 | A1 |
20200155116 | Donhowe et al. | May 2020 | A1 |
20200170623 | Averbuch | Jun 2020 | A1 |
20200170720 | Ummalaneni | Jun 2020 | A1 |
20200179058 | Barbagli et al. | Jun 2020 | A1 |
20200188038 | Donhowe et al. | Jun 2020 | A1 |
20200205903 | Srinivasan et al. | Jul 2020 | A1 |
20200205904 | Chopra | Jul 2020 | A1 |
20200214664 | Zhao et al. | Jul 2020 | A1 |
20200222666 | Chan et al. | Jul 2020 | A1 |
20200229679 | Zhao et al. | Jul 2020 | A1 |
20200242767 | Zhao et al. | Jul 2020 | A1 |
20200261175 | Fenech | Aug 2020 | A1 |
20200268240 | Blumenkranz et al. | Aug 2020 | A1 |
20200275860 | Duindam | Sep 2020 | A1 |
20200289023 | Duindam et al. | Sep 2020 | A1 |
20200297442 | Adebar et al. | Sep 2020 | A1 |
20200305983 | Yampolsky et al. | Oct 2020 | A1 |
20200315554 | Averbuch et al. | Oct 2020 | A1 |
20200330795 | Sawant et al. | Oct 2020 | A1 |
20200345436 | Kowshik et al. | Nov 2020 | A1 |
20200352427 | Deyanov | Nov 2020 | A1 |
20200352675 | Averbuch | Nov 2020 | A1 |
20200364865 | Donhowe et al. | Nov 2020 | A1 |
20200367726 | Landey et al. | Nov 2020 | A1 |
20200383750 | Kemp et al. | Dec 2020 | A1 |
20200391010 | Fenech et al. | Dec 2020 | A1 |
20200406002 | Romo et al. | Dec 2020 | A1 |
Number | Date | Country |
---|---|---|
0013237 | Jul 2003 | BR |
0116004 | Jun 2004 | BR |
112018003862 | Oct 2018 | BR |
486540 | Sep 2016 | CZ |
2709512 | Aug 2017 | CZ |
2884879 | Jan 2020 | CZ |
102009043523 | Apr 2011 | DE |
3326551 | May 2018 | EP |
3367915 | Jul 2019 | EP |
3413830 | Sep 2019 | EP |
3576598 | Dec 2019 | EP |
3478161 | Feb 2020 | EP |
3641686 | Apr 2020 | EP |
3644885 | May 2020 | EP |
3644886 | May 2020 | EP |
H11309 | Jan 1999 | JP |
2003290131 | Oct 2003 | JP |
2005287900 | Oct 2005 | JP |
2006204635 | Aug 2006 | JP |
2009078133 | Apr 2009 | JP |
2010279695 | Dec 2010 | JP |
2013506861 | Feb 2013 | JP |
PA03005028 | Jan 2004 | MX |
225663 | Jan 2005 | MX |
226292 | Feb 2005 | MX |
246862 | Jun 2007 | MX |
265247 | Mar 2009 | MX |
284569 | Mar 2011 | MX |
0010456 | Mar 2000 | WO |
0167035 | Sep 2001 | WO |
2015109121 | Jul 2015 | WO |
2015149040 | Oct 2015 | WO |
Entry |
---|
“A finite element analysis of the effects of the abdomen on regional lung expansion” by S. Ganesan et al. Respiration Physiology. 99. pp. 341-353. (Year: 1995). |
“Computed Tomographic-Based Volumetric Reconstruction of the Pulmonary System in Scoliosis” by C.J. Adam et al. J Pediatr Orthop. vol. 27, Issue 6. pp. 677-681. (Year: 2007). |
“Finite Elements Modeling in Diagnostics of Small Closed Pneumothorax” by J. Lorkowski et al. Advs Exp Med Biol—Neuroscience and Respiration 15:7-13. (Year: 2015). |
“Lung Lesion Extraction Using a Toboggan Based Growing Automatic Segmentation Approach” by J. Song et al. IEEE Trans Med Imag. vol. 35, No. 1. (Year: 2016). |
“Lung Mesh Generation to Simulate Breathing Motion with a Finite Element Method” by P-F Villard et al. IEEE Proc 8th Int Conf Information Visualisation. (Year: 2004). |
“Smoothing Lung Segmentation Surfaces in 3D X-ray CT Images using Anatomic Guidance” by S. Ukil et al. Medical Imaging, pp. 1066-1075. (Year: 2004). |
Australian Examination Report dated May 25, 2018 in AU Appln. No. 2017202106. |
Canadian Office Action dated Jun. 7, 2018 issued in corresponding CA Appln. No. 2,962,695. |
Chinese Office Action dated Jul. 4, 2018 issued in corresponding CN Appln. No. 201710204462.9. |
European Search Report dated Aug. 3, 2017 issued in corresponding EP Application No. 17164275.4-1666. |
Japanese Office Action dated Mar. 5, 2018 issued in corresponding JP Appln. No. 2017-068088. |
PCT Search Report and Written Opinion issued in PCT Application No. PCT/US2019/040265 dated Oct. 25, 2019, 11 pages. |
PR Web Online Visibility from Vocus, Press Release dated Apr. 10, 2018, “Aether to Launch AI Organ Printing Software,” available at http://www.prweb.com/releases/2018/04/prweb15401486.htm [retrieved on Oct. 23, 2018]. |
Extended European Search Report issued in European Patent Application No. 19840041.8 dated Mar. 25, 2022. |
Number | Date | Country | |
---|---|---|---|
20220015831 A1 | Jan 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16045996 | Jul 2018 | US |
Child | 17385522 | US |